On July 2, 2025, the European Commission released its communication “Choose Europe for life sciences. A strategy to position the EU as the world’s most attractive place for life sciences by 2030” (the Strategy).
...more
7/17/2025
/ Biotechnology ,
Clinical Trials ,
EU ,
Healthcare ,
Innovation ,
Investment ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Research and Development
The UPC decides that the defendant’s financial situation and location matter.
On 30 October 2023, the Munich Central Division of the UPC (the Court) issued an order stating that NanoString must provide security to Harvard...more
12/20/2023
/ Enforcement Actions ,
EU ,
Ex Parte ,
Intellectual Property Protection ,
Life Sciences ,
Litigation Fees & Costs ,
Patent Litigation ,
Patents ,
Revocation ,
UK ,
Unified Patent Court
In its two Confédération Paysanne decisions (cases C-528/161 and C-688/21), the Court of Justice of the European Union limited the exclusion of plants and products obtained by new genomic techniques (NGTs) from the...more
9/8/2023
/ Environmental Policies ,
EU ,
EU Directive ,
European Commission ,
European Court of Justice (ECJ) ,
Genetically Engineered Seed ,
GMO ,
Legislative Agendas ,
Life Sciences ,
Proposed Regulation ,
Regulatory Agenda ,
Regulatory Requirements ,
Risk Assessment
Connected medical devices are used to assist with diagnosing, monitoring or treating a medical condition and thereby facilitate the remote management of a medical condition by healthcare professionals. Such medical devices...more
4/26/2023
/ Algorithms ,
Anticompetitive Agreements ,
Artificial Intelligence ,
Connected Items ,
DATA Act ,
EU ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Facilities ,
Legislative Agendas ,
Life Sciences ,
Machine Learning ,
Medical Devices ,
New Legislation ,
Pharmaceutical Industry ,
Proposed Legislation
On 25 November 2020, the European Commission announced in its Communication for a Pharmaceutical Strategy for Europe a thorough review of the EU pharmaceutical legislation, which was originally planned for 2022....more